Atlas Trials

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

Clinical trial NCT04394858 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04394858
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Adrenal Gland PheochromocytomaAdvanced ParagangliomaMetastatic Adrenal Gland PheochromocytomaMetastatic ParagangliomaStage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8Unresectable Adrenal Gland PheochromocytomaUnresectable Paraganglioma
Start date
2021-03-17
Primary completion
2028-03-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.